FI960268A - Metod för diagnos av sjukdom genom att bestämma expression av perkursorer för GAGE-tumöravstötningsantigen - Google Patents

Metod för diagnos av sjukdom genom att bestämma expression av perkursorer för GAGE-tumöravstötningsantigen Download PDF

Info

Publication number
FI960268A
FI960268A FI960268A FI960268A FI960268A FI 960268 A FI960268 A FI 960268A FI 960268 A FI960268 A FI 960268A FI 960268 A FI960268 A FI 960268A FI 960268 A FI960268 A FI 960268A
Authority
FI
Finland
Prior art keywords
tumor rejection
rejection antigen
antigen precursors
expression
determining
Prior art date
Application number
FI960268A
Other languages
English (en)
Finnish (fi)
Other versions
FI960268A0 (sv
Inventor
Den Eynde Benoit Van
Thierry Boon-Falleur
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of FI960268A publication Critical patent/FI960268A/sv
Publication of FI960268A0 publication Critical patent/FI960268A0/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
FI960268A 1993-07-22 1996-01-19 Metod för diagnos av sjukdom genom att bestämma expression av perkursorer för GAGE-tumöravstötningsantigen FI960268A0 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9603993A 1993-07-22 1993-07-22
US08/250,162 US5610013A (en) 1993-07-22 1994-05-27 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
PCT/US1994/007878 WO1995003422A1 (en) 1993-07-22 1994-07-13 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors

Publications (2)

Publication Number Publication Date
FI960268A true FI960268A (sv) 1996-01-19
FI960268A0 FI960268A0 (sv) 1996-01-19

Family

ID=22254881

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960268A FI960268A0 (sv) 1993-07-22 1996-01-19 Metod för diagnos av sjukdom genom att bestämma expression av perkursorer för GAGE-tumöravstötningsantigen

Country Status (14)

Country Link
US (1) US5610013A (sv)
EP (1) EP0711355B1 (sv)
JP (1) JP3641692B2 (sv)
KR (1) KR100281178B1 (sv)
CN (1) CN1059465C (sv)
AT (1) ATE223435T1 (sv)
AU (1) AU677687B2 (sv)
CA (1) CA2167692C (sv)
DE (1) DE69431301T2 (sv)
FI (1) FI960268A0 (sv)
NO (1) NO960158L (sv)
NZ (1) NZ269435A (sv)
TW (1) TW498104B (sv)
WO (1) WO1995003422A1 (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013481A (en) * 1993-07-22 2000-01-11 Ludwig Institute For Cancer Research Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof
US5648226A (en) * 1993-07-22 1997-07-15 Ludwig Institute For Cancer Research Isolated peptides derived from tumor rejection antigens, and their use
US5858689A (en) * 1993-07-22 1999-01-12 Ludwig Institute For Cancer Research Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof
US6939707B2 (en) * 1993-07-22 2005-09-06 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode GAGE genes and uses thereof
ZA975632B (en) * 1996-06-25 1999-01-25 Ludwig Inst Cancer Res Brain glycogen phosphorylase cancer antigen
PT970206E (pt) 1997-01-27 2008-10-28 Ludwig Inst Cancer Res Ácidos nucleicos lage-1 associados a tumores
US5879892A (en) * 1997-04-25 1999-03-09 Ludwig Institute For Cancer Research Leukemia associated genes
AU3587599A (en) * 1997-11-28 1999-06-16 Invitrogen Corporation Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo
US5905145A (en) * 1998-03-06 1999-05-18 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof
US6245525B1 (en) * 1998-07-27 2001-06-12 Ludwig Institute For Cancer Research Tumor associated nucleic acids and uses therefor
US7001999B1 (en) * 1998-04-15 2006-02-21 Ludwig Institute For Cancer Research Tumor associated nucleic acids and uses therefor
AU3753499A (en) * 1998-04-20 1999-11-08 Paul B. Fisher Colon cancer-associated antigens and their diagnostic and therapeutic uses
US6140050A (en) * 1998-06-26 2000-10-31 Ludwig Institute For Cancer Research Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
US6509172B1 (en) * 1998-09-30 2003-01-21 Ludwig Institute For Cancer Research Isolated, truncated nucleic acid which are members of the gage, and uses thereof
EP1222274A2 (en) 1999-10-19 2002-07-17 Ludwig Institute For Cancer Research Mage-a12 antigenic peptides and uses thereof
WO2001053349A2 (en) * 2000-01-21 2001-07-26 Ludwig Institute For Cancer Research Small cell lung cancer associated antigens and uses therefor
JP2003529350A (ja) * 2000-02-15 2003-10-07 キュラジェン コーポレイション ポリペプチドおよびそれをコードする核酸
EP1605045A3 (en) * 2000-02-15 2006-03-01 Curagen Corporation Polypeptides and nucleic acids encoding same
AU2003303082B2 (en) 2002-01-30 2009-07-02 Dana-Farber Cancer Institute, Inc. Compositions and methods related to TIM-3, a Th1-specific cell surface molecule
US7311914B2 (en) * 2002-08-13 2007-12-25 Ludwig Institute For Cancer Research MAGE-A4 antigenic peptides and uses thereof
EP1545610A4 (en) * 2002-09-06 2006-11-08 Mannkind Corp EPITOPE SEQUENCES
US7178491B2 (en) * 2003-06-05 2007-02-20 Caterpillar Inc Control system and method for engine valve actuator
AU2004249254B2 (en) * 2003-06-17 2010-07-08 Mannkind Corporation Combinations of tumor-associated antigens for the treatment of various types of cancers
US20060008468A1 (en) * 2004-06-17 2006-01-12 Chih-Sheng Chiang Combinations of tumor-associated antigens in diagnostics for various types of cancers
US20060159689A1 (en) * 2004-06-17 2006-07-20 Chih-Sheng Chiang Combinations of tumor-associated antigens in diagnostics for various types of cancers
CA2571283C (en) 2004-06-23 2013-10-22 University Of Texas System Methods and compositions for the detection of biological molecules using a two particle complex
WO2006071989A2 (en) * 2004-12-29 2006-07-06 Mannkind Corporation Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
WO2006071983A2 (en) 2004-12-29 2006-07-06 Mannkind Corporation Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
BRPI0611794A2 (pt) 2005-06-17 2010-09-28 Mannkind Corp métodos e composições para induzir respostas imunes multivalentes contra epìtopos dominantes e subdominantes, expressos em células de cáncer e estroma tumoral
WO2011127129A1 (en) * 2010-04-06 2011-10-13 Holaday John W Methods of treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105538A (en) * 1977-01-21 1978-08-08 Mattox William J Process for the refining of used motor oils and products thereof
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
DE4238416A1 (de) * 1992-11-13 1994-05-19 Max Planck Gesellschaft Bestimmung von Peptidmotiven auf MHC-Molekülen

Also Published As

Publication number Publication date
TW498104B (en) 2002-08-11
ATE223435T1 (de) 2002-09-15
NO960158D0 (no) 1996-01-15
FI960268A0 (sv) 1996-01-19
EP0711355A4 (en) 1998-05-06
EP0711355A1 (en) 1996-05-15
CN1059465C (zh) 2000-12-13
NZ269435A (en) 1997-11-24
AU7332294A (en) 1995-02-20
NO960158L (no) 1996-01-22
WO1995003422A1 (en) 1995-02-02
CN1127532A (zh) 1996-07-24
JPH09504165A (ja) 1997-04-28
EP0711355B1 (en) 2002-09-04
AU677687B2 (en) 1997-05-01
US5610013A (en) 1997-03-11
KR100281178B1 (ko) 2001-04-02
DE69431301D1 (de) 2002-10-10
JP3641692B2 (ja) 2005-04-27
DE69431301T2 (de) 2003-07-31
CA2167692A1 (en) 1995-02-02
CA2167692C (en) 2009-07-07

Similar Documents

Publication Publication Date Title
FI960268A0 (sv) Metod för diagnos av sjukdom genom att bestämma expression av perkursorer för GAGE-tumöravstötningsantigen
ZA958039B (en) Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
FI956019A (sv) Isolerade peptider, som bildar komplex med MHC-molekyl HLA-C-klon-10, och användning av dessa
PT845032E (pt) Moleculas isoladas de acidos nucleicos peptidos que formam complexos com a molecula a2-alh do cph e suas aplicacoes
ATE258379T1 (de) Nukleinsäure, die für einen tumor abstossungsantigenvorläufer kodiert
ATE234858T1 (de) Isolierte und verkürzte nukleinsäuremoleküle kodierend für gage-tumorabstossungsantigen
CY1112953T1 (el) Χρηση των αντι-cd100 αντισωματων
NZ332369A (en) Isolated nucleic acid molecules which code for GAGE tumor rejection antigen, the tumor rejection antigen, and uses thereof
TW372973B (en) Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof
ATE90793T1 (de) Antikoerper, verfahren zu ihrer herstellung, klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren.
CA2165435A1 (en) Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof